Thursday, January 23, 2014

Is this Alzheimer's Drug on the Fast Track to Approval?

We’re focusing on the memory, Alzheimer’s Disease, and people’s ability to access their memories and be able to live more normally.

The Food and Drug Administration has given these tests a special protocol assessment, meaning the therapy could win quicker approval if the tests are successful.

Learn more from CBS Boston

To learn more about Alzheimer's and Dementia care visit the Alzheimer's Reading Room